Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John R. Moore currently holds 12,312 shares of ARRAY BIOPHARMA INC (ARRY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John R. Moore has been a net seller of ARRY stock. They have purchased $0 and sold $5.6M worth of shares.
John R. Moore's most recent insider trade was on Aug 12, 2025, when they sold 5,781 shares at $0.00 per share.
John R. Moore serves as Executive at ARRAY BIOPHARMA INC (ARRY). They have executed 114 insider transactions totaling $5.6M over their tenure at the company.
John R. Moore holds the position of Executive at ARRAY BIOPHARMA INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
John R. Moore has shown a selling trading pattern, with $0 in total purchases and $5.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John R. Moore was on Sep 20, 2024, when they sold $1.4M worth of EWTX shares. This transaction involved 50,000 shares at $28.37 per share.
John R. Moore currently owns 12,312 shares of ARRAY BIOPHARMA INC (ARRY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John R. Moore's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John R. Moore has 114 Form 4 filings on record as an insider at ARRAY BIOPHARMA INC.
Set alerts for John R. Moore and 40,000+ other insiders.